Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects (SWEAR)

This study is not yet open for participant recruitment.
Verified January 2014 by Azienda Ospedaliera San Gerardo di Monza
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Giuseppe Lapadula, Azienda Ospedaliera San Gerardo di Monza
ClinicalTrials.gov Identifier:
NCT02042001
First received: January 20, 2014
Last updated: NA
Last verified: January 2014
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)